123x Filetype PDF File size 2.35 MB Source: psnc.org.uk
www.pwc.co.uk The value of community pharmacy – detailed report PSNC September 2016 The value of community pharmacy Contents Key findings ................................................................................................................................................................... i Glossary ........................................................................................................................................................................ iv Introduction ................................................................................................................................................................... 7 Context ........................................................................................................................................................................... 7 Report structure ............................................................................................................................................................ 7 Public health ................................................................................................................................................................. 9 Emergency hormonal contraception services ............................................................................................................10 1. Introduction .............................................................................................................................................................10 2. Description of activity .............................................................................................................................................10 3. Contribution of community pharmacy ................................................................................................................... 12 4. Approach to estimating contribution of community pharmacy ........................................................................... 14 5. Key results and sensitivities ................................................................................................................................... 22 Needle and syringe programmes ............................................................................................................................... 26 1. Introduction ............................................................................................................................................................ 26 2. Description of activity ............................................................................................................................................ 26 3. Contribution of community pharmacy .................................................................................................................. 29 4. Approach to estimating contribution of community pharmacy .......................................................................... 30 5. Key results and sensitivities ................................................................................................................................... 40 Supervised consumption services .............................................................................................................................. 47 1. Introduction ............................................................................................................................................................ 47 2. Description of activity ............................................................................................................................................ 47 3. Contribution of community pharmacy .................................................................................................................. 49 4. Approach to estimating contribution of community pharmacy .......................................................................... 50 5. Key results and sensitivities .................................................................................................................................... 61 Self-care support......................................................................................................................................................... 66 Minor ailments advice ................................................................................................................................................ 67 1. Introduction ............................................................................................................................................................ 67 2. Description of activity ............................................................................................................................................ 67 3. Contribution of community pharmacy .................................................................................................................. 68 4. Approach to estimating the contribution of community pharmacy .................................................................... 70 5. Key results and sensitivities ................................................................................................................................... 78 Medicines support ...................................................................................................................................................... 83 The value of community pharmacy Managing prescribing errors/clarifying prescriptions ............................................................................................. 84 1. Introduction ............................................................................................................................................................ 84 2. Description of service ............................................................................................................................................. 84 3. Contribution of community pharmacy .................................................................................................................. 85 4. Approach to estimating contribution of community pharmacy .......................................................................... 87 5. Key results and sensitivities ................................................................................................................................... 96 Medicines adjustments ............................................................................................................................................ 100 1. Introduction .......................................................................................................................................................... 100 2. Description of activity .......................................................................................................................................... 100 3. Contribution of community pharmacy ................................................................................................................ 102 4. Approach to estimating the contribution of community pharmacy .................................................................. 102 5. Key results and sensitivities ..................................................................................................................................105 Delivering prescriptions ............................................................................................................................................ 107 1. Introduction ........................................................................................................................................................... 107 2. Description of activity ........................................................................................................................................... 107 3. Contribution of community pharmacy ................................................................................................................ 108 4. Approach to estimating contribution of community pharmacy ........................................................................ 109 5. Key results and sensitivities ................................................................................................................................... 111 Managing drug shortages .......................................................................................................................................... 114 1. Introduction ......................................................................................................................................................... 114 2. Description of activity .......................................................................................................................................... 114 3. Contribution of community pharmacy ............................................................................................................... 115 4. Approach to estimating the contribution of community pharmacy .................................................................. 116 5. Key results and sensitivities ................................................................................................................................ 122 Sustaining supply of medicines in emergencies ...................................................................................................... 126 1. Introduction ......................................................................................................................................................... 126 2. Description of activity .......................................................................................................................................... 126 3. Contribution of community pharmacy ............................................................................................................... 129 4. Approach to estimating contribution of community pharmacy ........................................................................ 129 5. Key results and sensitivities ................................................................................................................................ 136 Medicines Use Reviews (MUR) ................................................................................................................................ 141 1. Introduction ........................................................................................................................................................... 141 2. Description of activity ........................................................................................................................................... 141 3. Contribution of community pharmacy ................................................................................................................. 142 4. Approach to estimating contribution of community pharmacy ......................................................................... 142 The value of community pharmacy 5. Conclusions ............................................................................................................................................................ 146 New Medicine Service (NMS) ................................................................................................................................... 147 1. Introduction ........................................................................................................................................................... 147 2. Description of activity ........................................................................................................................................... 147 3. Contribution of community pharmacy ................................................................................................................ 148 4. Approach to estimating contribution of community pharmacy ........................................................................ 148 5. Key results and sensitivities .................................................................................................................................. 149 Appendix 1 – PSNC/PwC Pharmacy survey ............................................................................................................. 151 Introduction ............................................................................................................................................................... 151 Questionnaire ............................................................................................................................................................ 151 Survey results ............................................................................................................................................................. 152 Respondent profile .................................................................................................................................................... 153 Appendix 2 – PSNC/PwC Data collection ................................................................................................................ 156 Introduction ............................................................................................................................................................... 156 Data collection form .................................................................................................................................................. 156 Results of the data collection .................................................................................................................................... 157 Respondent profile .................................................................................................................................................... 158 Appendix 3 - Estimating the volume of locally commissioned services ................................................................. 161 Introduction ............................................................................................................................................................... 161 Approach to estimating the scale of provision ......................................................................................................... 161 Appendix 4 - Valuing time savings ........................................................................................................................... 165 Introduction ............................................................................................................................................................... 165 Average distance and average journey time ............................................................................................................. 165 Average consultation time......................................................................................................................................... 169 Value of time .............................................................................................................................................................. 170 Valuation areas not assessed .................................................................................................................................... 171 Appendix 5 – Valuing wellbeing ............................................................................................................................... 173 Introduction ............................................................................................................................................................... 173 Approach .................................................................................................................................................................... 173 Results ........................................................................................................................................................................ 173 Appendix 6 - Pharmacy staff time and costs ............................................................................................................ 174 Introduction ............................................................................................................................................................... 174 Approach .................................................................................................................................................................... 174 References .................................................................................................................................................................. 176
no reviews yet
Please Login to review.